Article

Discussing Cancer Symptom Management With Nurse Darcy Burbage

Author(s):

CURE staff

Cancer survivors often experience physical and psychosocial long-term and late effects after treatment ends.

Cancer survivors often experience physical and psychosocial long-term and late effects after treatment ends. Although most individuals experience some types of side effects during treatment, it is often surprising to survivors that some side effects can linger on after treatment is over, or can appear later on.

Nurses and patients have a lot to learn from each other to help us better understand and manage the effects of cancer treatment.

Please join our guest host Darcy Burbage (@DarcyBurbage on Twitter) as we discuss the challenges of treatment-related changes and share resources and advice.

Darcy is a survivorship nurse navigator and oncology nurse advocate, focused on bringing evidence- based strategies for quality survivorship care to oncology. Darcy guest blogs for Oncology Nursing News and also has written for the Association of Community Cancer Centers. She is a highly regarded nurse leader, currently serving as Chair of the ONS Communities Advisory Panel with the Oncology Nursing Society.

We hope to see you Thursday, July 7th on Twitter at 9 p.m. EST. Don’t forget to include the #CureConnect hashtag in all of your responses! Read more here about the #CureConnect chat and how to participate.

Tweet: I’ll be at the #CureConnect chat July 7 at 9pm EST with @cure_magazine and @oncnursingnews talking symptom management. Join me!
Related Videos
Image of man with grey hair.
Image of woman with black hair.
1 expert is featured in this series.
Image of a smiling woman with brown hair.
Image of a woman with short brown hair, wearing glasses.
Image of man with brown hair.
Related Content
Image of "FDA Breakthrough Therapy Designation" with a gold background.
December 21st 2024

FDA Grants Jemperli Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer

Ryan Scott
Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite instability-high rectal cancer.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Image of a smiling woman with brown hair.
December 20th 2024

How to Self Advocate When Insurance Says No to Cancer Treatment Coverage

Ashley Chan
When insurance denies coverage of cancer treatment, patients with cancer don’t need to take no for an answer, an expert explained.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of a man with blond hair wearing rectangular glasses.
December 20th 2024

Reflecting on Cancer During a Christmas Morning Run

Brian Sluga
A reflective Christmas morning run, following a cancer diagnosis, inspires profound gratitude for life and a renewed commitment to living a meaningful life.
Illustration of biliary tract cancer.
December 20th 2024

NFL Star Randy Moss Undergoing Cancer Treatment, Montell Jordan Shares Update and More

Alex Biese Ashley Chan
From a Pro Football Hall of Famer announcing his diagnosis to an R&B star’s latest update, here’s what’s happening in the cancer space this week.